| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |